Skip to main content
logo
Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
187.70
+6.20 (3.42%)
Aug 20, 2026, 4:09 PM HKT

Duality Biotherapeutics Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Market Capitalization
16,97826,664--
Market Cap Growth
-44.39%---
Enterprise Value
13,38322,676--
Last Close Price
187.70298.20--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
PS Ratio
8.2412.94--
PB Ratio
6.299.87--
P/TBV Ratio
6.309.89--
P/FCF Ratio
83.33130.88--
P/OCF Ratio
78.41123.14--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
6.4911.00--
EV/FCF Ratio
65.69111.30--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.060.060.000.00
Debt / EBITDA Ratio
---0.01
Debt / FCF Ratio
0.820.820.020.01
Net Debt / Equity Ratio
-1.33-1.330.691.01
Net Debt / EBITDA Ratio
7.147.147.63-1.53
Net Debt / FCF Ratio
-17.64-17.64-4.94-1.40
Asset Turnover
0.620.621.08-
Quick Ratio
3.523.520.480.50
Current Ratio
3.653.650.490.52
Return on Equity (ROE)
-1282.14%-1282.14%--
Return on Assets (ROA)
-9.61%-9.61%-6.51%-
Return on Capital Employed (ROCE)
-16.20%-16.20%10.50%-69.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-17.01%-10.83%--
FCF Yield
1.20%0.76%--
Buyback Yield / Dilution
-714.45%-714.45%--